131 related articles for article (PubMed ID: 11596040)
1. Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data.
Kato I; Severson RK; Schwartz AG
Cancer; 2001 Oct; 92(8):2211-9. PubMed ID: 11596040
[TBL] [Abstract][Full Text] [Related]
2. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas.
Lin SS; Clarke CA; Prehn AW; Glaser SL; West DW; O'Malley CD
Cancer; 2002 Feb; 94(4):1175-82. PubMed ID: 11920489
[TBL] [Abstract][Full Text] [Related]
3. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
Chen CT; Li L; Brooks G; Hassett M; Schrag D
Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
[TBL] [Abstract][Full Text] [Related]
4. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
5. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
[TBL] [Abstract][Full Text] [Related]
6. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
Brenner H; Jansen L
J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902
[TBL] [Abstract][Full Text] [Related]
7. Long-term cancer patient survival in the United States.
Wingo PA; Ries LA; Parker SL; Heath CW
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):271-82. PubMed ID: 9568781
[TBL] [Abstract][Full Text] [Related]
8. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
9. The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
Feuer EJ; Rabin BA; Zou Z; Wang Z; Xiong X; Ellis JL; Steiner JF; Cynkin L; Nekhlyudov L; Bayliss E; Hankey BF
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):265-74. PubMed ID: 25417240
[TBL] [Abstract][Full Text] [Related]
10. Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis.
Muralidhar V; Mahal BA; Nguyen PL
Radiat Oncol; 2015 Jul; 10():155. PubMed ID: 26220664
[TBL] [Abstract][Full Text] [Related]
11. Projecting SEER cancer survival rates to the US: an ecological regression approach.
Mariotto A; Capocaccia R; Verdecchia A; Micheli A; Feuer EJ; Pickle L; Clegg LX
Cancer Causes Control; 2002 Mar; 13(2):101-11. PubMed ID: 11936816
[TBL] [Abstract][Full Text] [Related]
12. Conditional survival in advanced colorectal cancer and surgery.
Wancata LM; Banerjee M; Muenz DG; Haymart MR; Wong SL
J Surg Res; 2016 Mar; 201(1):196-201. PubMed ID: 26850202
[TBL] [Abstract][Full Text] [Related]
13. Conditional survival of cancer patients: an Australian perspective.
Yu XQ; Baade PD; O'Connell DL
BMC Cancer; 2012 Oct; 12():460. PubMed ID: 23043308
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
15. Conditional survival among patients with carcinoma of the lung.
Merrill RM; Henson DE; Barnes M
Chest; 1999 Sep; 116(3):697-703. PubMed ID: 10492274
[TBL] [Abstract][Full Text] [Related]
16. A National Study of Survival Trends and Conditional Survival in Nasopharyngeal Carcinoma: Analysis of the National Population-Based Surveillance Epidemiology and End Results Registry.
Lv JW; Huang XD; Chen YP; Zhou GQ; Tang LL; Mao YP; Li WF; Lin AH; Ma J; Sun Y
Cancer Res Treat; 2018 Apr; 50(2):324-334. PubMed ID: 28421724
[TBL] [Abstract][Full Text] [Related]
17. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
18. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
19. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects.
Baade PD; Youlden DR; Chambers SK
Med J Aust; 2011 Jan; 194(2):73-7. PubMed ID: 21241220
[TBL] [Abstract][Full Text] [Related]
20. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
